Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation.
暂无分享,去创建一个
D. Steinhilber | I. Fleming | B. Freeman | B. Hofmann | G. Geisslinger | H. Heide | T. Maier | K. Awwad | Timo Frömel | Ann-Kathrin Häfner | J. Roos | N. Lill | Svenja Steinbrink | J. Isaak | Ann‐Kathrin Häfner
[1] N. A. Stewart,et al. Modulation of Nitro-fatty Acid Signaling , 2013, The Journal of Biological Chemistry.
[2] N. A. Stewart,et al. Modulation of Nitro-Fatty Acid Signaling: Prostaglandin Reductase-1 is a Nitroalkene Reductase , 2013 .
[3] A. Reichert,et al. Complexome profiling identifies TMEM126B as a component of the mitochondrial complex I assembly complex. , 2012, Cell metabolism.
[4] O. Werz,et al. Inhibition of 5-lipoxygenase by U73122 is due to covalent binding to cysteine 416. , 2012, Biochimica et biophysica acta.
[5] P. Montuschi,et al. New perspectives in pharmacological treatment of mild persistent asthma. , 2011, Drug discovery today.
[6] G. Schneider,et al. Dimerization of human 5-lipoxygenase , 2011, Biological chemistry.
[7] B. Freeman,et al. Formation and signaling actions of electrophilic lipids. , 2011, Chemical reviews.
[8] C. Carlberg,et al. Electrophilic Nitro-fatty Acids Activate NRF2 by a KEAP1 Cysteine 151-independent Mechanism* , 2011, Journal of Biological Chemistry.
[9] M. Peters-Golden,et al. Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression. , 2011, The Journal of clinical investigation.
[10] C. Funk. Leukotriene Inflammatory Mediators Meet Their Match , 2011, Science Translational Medicine.
[11] A. Brash,et al. The Structure of Human 5-Lipoxygenase , 2011, Science.
[12] S. Cuzzocrea,et al. The 5‐lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages , 2010, British journal of pharmacology.
[13] M. Rossi,et al. 5-lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection. , 2010, Microbes and infection.
[14] B. Freeman,et al. Redox signaling in inflammation: interactions of endogenous electrophiles and mitochondria in cardiovascular disease , 2010, Annals of the New York Academy of Sciences.
[15] Y. E. Chen,et al. Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions. , 2010, The Journal of biological chemistry.
[16] B. Freeman,et al. Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment. , 2010, Current opinion in pharmacology.
[17] Hai-ying Liu,et al. Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice. , 2010, American journal of physiology. Renal physiology.
[18] S. Ylä-Herttuala,et al. Nrf2-dependent and -independent Responses to Nitro-fatty Acids in Human Endothelial Cells , 2009, The Journal of Biological Chemistry.
[19] Paolo Montuschi,et al. LC/MS/MS analysis of leukotriene B4 and other eicosanoids in exhaled breath condensate for assessing lung inflammation. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[20] M. P. Cole,et al. Nitro-fatty Acid Metabolome: Saturation, Desaturation, β-Oxidation, and Protein Adduction* , 2009, Journal of Biological Chemistry.
[21] Y. E. Chen,et al. Nitro-Fatty Acid Inhibition of Neointima Formation After Endoluminal Vessel Injury , 2008, Circulation research.
[22] M. Tarpey,et al. Nitro-oleic Acid, a Novel and Irreversible Inhibitor of Xanthine Oxidoreductase* , 2008, Journal of Biological Chemistry.
[23] Y. E. Chen,et al. Molecular recognition of nitrated fatty acids by PPARγ , 2008, Nature Structural &Molecular Biology.
[24] P. Montuschi. Leukotrienes, antileukotrienes and asthma. , 2008, Mini reviews in medicinal chemistry.
[25] O. Werz,et al. 5-Lipoxygenase: regulation of expression and enzyme activity. , 2007, Trends in biochemical sciences.
[26] Oliver Werz,et al. Therapeutic options for 5-lipoxygenase inhibitors. , 2006, Pharmacology & therapeutics.
[27] Jifeng Zhang,et al. Nitrated Fatty Acids: Endogenous Anti-inflammatory Signaling Mediators* , 2006, Journal of Biological Chemistry.
[28] J. Janssens,et al. [Leukotriene-modifiers in asthma treatment]. , 2006, Revue medicale suisse.
[29] Y. Chen,et al. Fatty Acid Transduction of Nitric Oxide Signaling , 2005, Journal of Biological Chemistry.
[30] C. Funk. Leukotriene modifiers as potential therapeutics for cardiovascular disease , 2005, Nature Reviews Drug Discovery.
[31] Jifeng Zhang,et al. Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor γ ligand , 2005 .
[32] N. Patel,et al. Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5‐lipoxygenase knockout mice and by the 5‐lipoxygenase inhibitor zileuton , 2004, Journal of leukocyte biology.
[33] A. Ramachandran,et al. Mechanisms of signal transduction mediated by oxidized lipids: the role of the electrophile-responsive proteome. , 2004, Biochemical Society transactions.
[34] O. Werz,et al. Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes. , 2002, Blood.
[35] C. Funk,et al. Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.
[36] B. Persson,et al. The N-terminal Domain of 5-Lipoxygenase Binds Calcium and Mediates Calcium Stimulation of Enzyme Activity* , 2000, The Journal of Biological Chemistry.
[37] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[38] H. Pahl. Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.
[39] O. Werz,et al. Selenium-dependent peroxidases suppress 5-lipoxygenase activity in B-lymphocytes and immature myeloid cells. The presence of peroxidase-insensitive 5-lipoxygenase activity in differentiated myeloid cells. , 1996, European journal of biochemistry.
[40] D. Steinhilber,et al. Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[41] B. Samuelsson,et al. Iron content of human 5-lipoxygenase, effects of mutations regarding conserved histidine residues. , 1993, The Journal of biological chemistry.
[42] J. Thirion,et al. Cloning of the guinea pig 5-lipoxygenase gene and nucleotide sequence of its promoter. , 1992, Biochemical and biophysical research communications.
[43] R. Egan,et al. Inhibition of mammalian 5-lipoxygenase by aromatic disulfides. , 1985, The Journal of biological chemistry.